166 related articles for article (PubMed ID: 10601613)
41. Intrapleural administration of pemetrexed: a pharmacokinetic study in an animal model.
Greillier L; Monjanel-Mouterde S; Fraticelli A; Devictor-Pierre B; Bouvenot J; Coltel N; Lamarche G; Astoul P
J Thorac Oncol; 2009 Mar; 4(3):404-8. PubMed ID: 19247087
[TBL] [Abstract][Full Text] [Related]
42. Intrapleural therapy with tetracycline and lidocaine for malignant pleural effusions.
Wallach HW
Chest; 1978 Feb; 73(2):246. PubMed ID: 620597
[No Abstract] [Full Text] [Related]
43. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
44. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M
Oncology; 1990; 47(1):55-61. PubMed ID: 2300386
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of aquaporin-1 on the pleura of rats with a tuberculous pleural effusion.
Du H; Xie C; He Q; Deng X
Lung; 2007 Dec; 185(6):325-36. PubMed ID: 17876668
[TBL] [Abstract][Full Text] [Related]
47. [Clinical treatment with cisplatin (CDDP) in pleural cavity for carcinomatous pleurisy--study of intraarterial concentration].
Hara S; Tagawa Y; Tsuji H; Oka T; Morinaga M; Shingu H; Nagayasu T; Ikuta Y; Ayabe H
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1509-11. PubMed ID: 8854792
[TBL] [Abstract][Full Text] [Related]
48. Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
Lardinois D; Jung FJ; Opitz I; Rentsch K; Latkoczy C; Vuong V; Varga Z; Rousson V; Günther D; Bodis S; Stahel R; Weder W
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):697-703. PubMed ID: 16515926
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
[TBL] [Abstract][Full Text] [Related]
50. [Palliative treatment of neoplastic pleural effusions. Talcing of the pleura under pleuroscopy with a mixture of talc and Virgimycin].
Scarbonchi J; Razzouk H
Mars Med; 1967; 104(11):939-47. PubMed ID: 4946935
[No Abstract] [Full Text] [Related]
51. [Remission of malignant pleural mesothelioma using high-dose cisplatin in monochemotherapy].
Ménard O; Seigneur J; Lamy P
Rev Mal Respir; 1991; 8(4):413-4. PubMed ID: 1924981
[TBL] [Abstract][Full Text] [Related]
52. [The kinetics of IL-2 after pleural administration in the treatment of neoplastic pleurisy].
Astoul P; Bertault-Peres P; Durand A; Boutin C
Rev Mal Respir; 1994; 11(1):29-35. PubMed ID: 8128091
[TBL] [Abstract][Full Text] [Related]
53. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase.
Cases Viedma E; Lorenzo Dus MJ; González-Molina A; Sanchis Aldás JL
Respir Med; 2006 Nov; 100(11):2037-42. PubMed ID: 16580190
[TBL] [Abstract][Full Text] [Related]
54. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
55. Subcutaneous seeding after ultrasound-guided placement of intrapleural catheter. An unusual complication of the intracavitary palliative treatment of pleural mesothelioma.
Sartori S; Nielsen I; Trevisani L; Tassinari D; Abbasciano V
Support Care Cancer; 1999 Sep; 7(5):362-4. PubMed ID: 10483823
[TBL] [Abstract][Full Text] [Related]
56. [Response and pharmacokinetics of cisplatin instilled into the pleural cavity].
Kudoh S; Takifugi N; Ryu S; Sakai N; Matsui K; Negoro S; Tamai S; Takada M; Kusunoki Y; Fukuoka M
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2161-5. PubMed ID: 4062316
[TBL] [Abstract][Full Text] [Related]
57. Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II study.
Monnet I; Breau JL; Moro D; Lena H; Eymard JC; Ménard O; Vuillez JP; Chokri M; Romet-Lemonne JL; Lopez M
Chest; 2002 Jun; 121(6):1921-7. PubMed ID: 12065358
[TBL] [Abstract][Full Text] [Related]
58. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
[TBL] [Abstract][Full Text] [Related]
59. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
[TBL] [Abstract][Full Text] [Related]
60. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
